Translocated LPS in the systemic circulation binds to LPS-binding protein (LBP), which is a marker for metabolic syndrome [11,12], and our previous study showed clear positive associations between plasma levels of interleukin-6 and LBP in patients with T2DM [13]. This evidence concerns the gene IL6 and metabolic syndrome.